Alembic Pharmaceuticals Ltd
NSE :APLLTD BSE :533573 Sector : PharmaceuticalsBuy, Sell or Hold APLLTD? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
06 Sep 1105.70 (-3.61%) | 05 Sep 1147.15 (2.77%) | 04 Sep 1116.20 (4.63%) | 03 Sep 1066.85 (-0.29%) | 02 Sep 1069.90 (1.02%) | 30 Aug 1059.10 (0.86%) | 29 Aug 1050.05 (-1.60%) | 28 Aug 1067.15 (-0.19%) | 27 Aug 1069.15 (-2.41%) | 26 Aug 1095.55 (-0.52%) | 23 Aug 1101.25 (-1.46%) | 22 Aug 1117.60 (0.93%) | 21 Aug 1107.25 (2.16%) | 20 Aug 1083.80 (1.20%) | 19 Aug 1070.95 (-1.70%) | 16 Aug 1089.45 (2.57%) | 14 Aug 1062.15 (-0.56%) | 13 Aug 1068.15 (-3.84%) | 12 Aug 1110.80 (-1.73%) | 09 Aug 1130.35 (-6.89%) | 08 Aug 1214.00 (-0.52%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
![](https://equitypandit.com/share-price/imgs/VBU.jpg)
Very Bullish
Medium Term Investors
![](https://equitypandit.com/share-price/imgs/VBU.jpg)
Very Bullish
Long Term Investors
![](https://equitypandit.com/share-price/imgs/VBU.jpg)
Very Bullish
Moving Averages
5 DMA
Bullish
1101.45
10 DMA
Bullish
1084.37
20 DMA
Bullish
1089.1
50 DMA
Bullish
1082.98
100 DMA
Bullish
1012.19
200 DMA
Bullish
955.93
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Sep 06, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 1226.96 | 1200.93 | 1125.95 | - | - |
R2 | 1200.93 | 1172.8 | 1119.2 | 1195.54 | - |
R1 | 1153.31 | 1155.41 | 1112.45 | 1142.53 | 1177.13 |
P | 1127.28 | 1127.28 | 1127.28 | 1121.89 | 1139.19 |
S1 | 1079.66 | 1099.15 | 1098.95 | 1068.88 | 1103.48 |
S2 | 1053.63 | 1081.76 | 1092.2 | 1048.24 | - |
S3 | 1006.01 | 1053.63 | 1085.45 | - | - |
Key Metrics
EPS
37.91
P/E
29.22
P/B
4.44
Dividend Yield
0.99%
Market Cap
21,734 Cr.
Face Value
2
Book Value
249.74
ROE
13.4%
EBITDA Growth
238.25 Cr.
Debt/Equity
0.13
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Alembic Pharmaceuticals Ltd Quaterly Results
Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | |
INCOME | 1497.82 | 1605.08 | 1633.46 | 1520.58 | 1564.15 |
PROFIT | 120.6 | 136.56 | 180.45 | 178.21 | 134.71 |
EPS | 6.14 | 6.95 | 9.23 | 8.48 | 6.84 |
Alembic Pharmaceuticals Ltd Quaterly Results
Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | |
INCOME | 1344.11 | 1487.79 | 1591.69 | 1481.77 | 1478.71 |
PROFIT | 97.53 | 133.84 | 233.24 | 201.87 | 176.19 |
EPS | 4.96 | 6.81 | 11.87 | 10.27 | 8.96 |
Profit & Loss (Figures in Rs. Crores)
Alembic Pharmaceuticals Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 2133.34 | 3269.05 | 3177.12 | 3179.9 | 4036.33 | 4821.28 | 5674.35 | 5404.72 | 5576.71 | 6399.77 | |
PROFIT | 282.92 | 720.05 | 403.59 | 408.91 | 582.26 | 861.88 | 1141.34 | 518.23 | 345.93 | 612.84 | |
EPS | 14.28 | 38.2 | 21.59 | 22.33 | 31.44 | 42.47 | 56.72 | 26.5 | 17.4 | 31.33 |
Alembic Pharmaceuticals Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 2094.48 | 3111.78 | 3036.4 | 2988.11 | 3747.11 | 4443.8 | 5311.44 | 5066.7 | 5079.7 | 5957.74 | |
PROFIT | 286.61 | 698.71 | 430.58 | 418.2 | 609.06 | 976.46 | 1091.34 | 540.74 | 346.68 | 665.49 | |
EPS | 14.49 | 37.07 | 22.85 | 22.39 | 32.42 | 51.43 | 55.79 | 27.65 | 17.64 | 33.91 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 39.31 | 39.31 | 39.31 | 39.31 | 37.7 | 37.7 | 37.7 | 37.7 | 37.7 | 37.7 |
Reserves Total | 4,778.89 | 4,331.16 | 5,198.23 | 5,027.66 | 3,181.71 | 2,681.12 | 2,182.44 | 1,864.63 | 1,559.66 | 846.94 |
Total Shareholders Funds | 4,818.2 | 4,370.47 | 5,237.54 | 5,066.97 | 3,219.41 | 2,718.82 | 2,220.14 | 1,902.33 | 1,597.36 | 884.64 |
Minority Interest | 0 | 0 | 0 | 0 | -28.96 | -0.79 | 0.31 | 0.11 | 0 | 0 |
Secured Loans | 100.04 | 165.07 | 0 | 0.02 | 0.04 | 34.93 | 46.53 | 8.27 | 113.71 | 233.5 |
Unsecured Loans | 413.12 | 556.95 | 717.11 | 583.59 | 1,747.45 | 1,093.5 | 661.25 | 80.24 | 0 | 30 |
Total Debt | 513.16 | 722.02 | 717.11 | 583.61 | 1,747.49 | 1,128.43 | 707.78 | 88.51 | 113.71 | 263.5 |
Other Liabilities | 109.51 | 106.2 | 95.82 | 85.52 | 147.81 | 52.03 | 40.76 | 57.22 | 41.28 | 22.21 |
Total Liabilities | 5,440.87 | 5,198.69 | 6,050.47 | 5,736.1 | 5,085.75 | 3,898.49 | 2,968.99 | 2,048.17 | 1,752.35 | 1,170.35 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 3,875.19 | 3,467.5 | 2,840.34 | 2,545.41 | 2,132.42 | 1,522.57 | 1,242.44 | 950.09 | 1,093.63 | 861.06 |
Less: Accumulated Depreciation | 1,328.48 | 1,069.05 | 1,042.49 | 756.99 | 580.58 | 364.12 | 249.06 | 150.69 | 385.54 | 314.19 |
Net Block | 2,546.71 | 2,398.45 | 1,797.85 | 1,788.42 | 1,551.84 | 1,158.45 | 993.38 | 799.4 | 708.09 | 546.87 |
Capital Work in Progress | 524.36 | 601.28 | 2,304.23 | 2,182.53 | 1,846.18 | 1,551.23 | 1,010.15 | 396.28 | 92.52 | 83.14 |
Investments | 93.02 | 96.33 | 118.4 | 236.28 | 17.62 | 48.76 | 41.64 | 49.88 | 86.73 | 2.26 |
Inventories | 1,643.54 | 1,475.27 | 1,609.7 | 1,486.15 | 1,187.53 | 967.26 | 733.93 | 632.75 | 569.79 | 382.77 |
Sundry Debtors | 1,024.84 | 1,046.4 | 807.13 | 348.58 | 864.75 | 488.92 | 526.34 | 338.82 | 350.48 | 361.17 |
Cash and Bank Balance | 126.57 | 82.27 | 69.43 | 105.84 | 80.75 | 205.62 | 89.92 | 159.6 | 450.83 | 26.83 |
Loans and Advances | 283.61 | 306.08 | 374.53 | 524.48 | 329.72 | 295.96 | 474.55 | 241.29 | 140.17 | 119.97 |
Total Current Assets | 3,078.56 | 2,910.02 | 2,860.79 | 2,465.05 | 2,462.75 | 1,957.76 | 1,824.74 | 1,372.46 | 1,511.27 | 890.74 |
Current Liabilities | 939.46 | 914.08 | 1,007.92 | 914.53 | 852.92 | 824.56 | 902.2 | 582.01 | 617.45 | 344.51 |
Provisions | 65.25 | 70.06 | 63.64 | 54.14 | 38.19 | 36 | 34.4 | 22.15 | 16.03 | 94.88 |
Total Current Liabilities & Provisions | 1,004.71 | 984.14 | 1,071.56 | 968.67 | 891.11 | 860.56 | 936.6 | 604.16 | 633.48 | 439.39 |
Net Current Assets | 2,073.85 | 1,925.88 | 1,789.23 | 1,496.38 | 1,571.64 | 1,097.2 | 888.14 | 768.3 | 877.79 | 451.34 |
Deferred Tax Assets | 300.92 | 206.15 | 203.57 | 184.71 | 148.06 | 122.12 | 83.04 | 55.3 | 23.81 | 16.25 |
Deferred Tax Liability | 131.28 | 83.14 | 197.69 | 188.92 | 160.25 | 140.86 | 118.5 | 92.23 | 66.55 | 47.68 |
Net Deferred Tax | 169.64 | 123.01 | 5.88 | -4.21 | -12.19 | -18.74 | -35.46 | -36.93 | -42.74 | -31.43 |
Other Assets | 33.29 | 53.74 | 34.88 | 36.7 | 110.66 | 61.59 | 71.14 | 71.24 | 29.96 | 118.15 |
Total Assets | 5,440.87 | 5,198.69 | 6,050.47 | 5,736.1 | 5,085.75 | 3,898.49 | 2,968.99 | 2,048.17 | 1,752.35 | 1,170.33 |
Contingent Liabilities | 54.61 | 109.23 | 62.87 | 100.46 | 117.8 | 103.98 | 94.04 | 82.07 | 108.61 | 104.84 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 39.31 | 39.31 | 39.31 | 39.31 | 37.7 | 37.7 | 37.7 | 37.7 | 37.7 | 37.7 |
Reserves Total | 4,869.6 | 4,374.99 | 5,251.03 | 5,062.5 | 3,308.31 | 2,674.71 | 2,156.94 | 1,829.62 | 1,493.04 | 795.86 |
Total Shareholders Funds | 4,908.91 | 4,414.3 | 5,290.34 | 5,101.81 | 3,346.01 | 2,712.41 | 2,194.64 | 1,867.32 | 1,530.74 | 833.56 |
Secured Loans | 100.04 | 165.07 | 0 | 0.02 | 0.04 | 34.93 | 46.53 | 8.28 | 0 | 163.61 |
Unsecured Loans | 391.95 | 544.86 | 706.12 | 583.59 | 1,686.99 | 1,024.35 | 575 | 0 | 0 | 30 |
Total Debt | 491.99 | 709.93 | 706.12 | 583.61 | 1,687.03 | 1,059.28 | 621.53 | 8.28 | 0 | 193.61 |
Other Liabilities | 109.51 | 106.2 | 95.82 | 85.52 | 146.51 | 51.33 | 40.43 | 57.22 | 41.28 | 22.21 |
Total Liabilities | 5,510.41 | 5,230.43 | 6,092.28 | 5,770.94 | 5,179.55 | 3,823.02 | 2,856.6 | 1,932.82 | 1,572.02 | 1,049.38 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 3,859.15 | 3,441.27 | 2,733.1 | 2,452.31 | 1,761.67 | 1,435.06 | 1,162.61 | 948.64 | 1,082.44 | 802.85 |
Less : Accumulated Depreciation | 1,323.49 | 1,063.82 | 962 | 678.49 | 485.21 | 349.62 | 244.31 | 149.63 | 385.19 | 314.17 |
Net Block | 2,535.66 | 2,377.45 | 1,771.1 | 1,773.82 | 1,276.46 | 1,085.44 | 918.3 | 799.01 | 697.25 | 488.68 |
Capital Work in Progress | 524.36 | 601.28 | 2,304.23 | 2,182.53 | 1,569.98 | 1,106.89 | 740.64 | 347.75 | 92.34 | 83.14 |
Investments | 226.68 | 229.27 | 219.36 | 343.09 | 833.25 | 506.39 | 298.89 | 103.04 | 37.46 | 33.33 |
Inventories | 1,353.07 | 1,275.13 | 1,396.83 | 1,341.96 | 1,073.18 | 891.41 | 669.93 | 574.62 | 533.72 | 382.48 |
Sundry Debtors | 1,340.12 | 1,201.2 | 988.33 | 421.86 | 784.11 | 539.78 | 621.66 | 467.41 | 371.5 | 337.94 |
Cash and Bank Balance | 26.49 | 28.46 | 21.9 | 61.44 | 37.13 | 150.8 | 15.63 | 7.21 | 284.81 | 4.41 |
Loans and Advances | 268.87 | 275.43 | 337.41 | 482.37 | 256.95 | 254.04 | 368.47 | 173.56 | 134.69 | 116.15 |
Total Current Assets | 2,988.55 | 2,780.22 | 2,744.47 | 2,307.63 | 2,151.37 | 1,836.03 | 1,675.69 | 1,222.8 | 1,324.72 | 840.98 |
Current Liabilities | 823.25 | 830.03 | 871.72 | 772.7 | 615.29 | 648.4 | 742.25 | 510.46 | 551.08 | 335.75 |
Provisions | 64.88 | 69.96 | 63.64 | 53.71 | 38.17 | 32.37 | 34.4 | 22.07 | 16 | 94.6 |
Total Current Liabilities & Provisions | 888.13 | 899.99 | 935.36 | 826.41 | 653.46 | 680.77 | 776.65 | 532.53 | 567.08 | 430.35 |
Net Current Assets | 2,100.42 | 1,880.23 | 1,809.11 | 1,481.22 | 1,497.91 | 1,155.26 | 899.04 | 690.27 | 757.64 | 410.63 |
Deferred Tax Assets | 210.11 | 161.3 | 151.29 | 142.8 | 114.49 | 95.59 | 73.86 | 48.45 | 23.7 | 16.25 |
Deferred Tax Liability | 131.28 | 83.14 | 197.69 | 188.92 | 160.25 | 140.86 | 118.5 | 92.23 | 66.33 | 47.68 |
Net Deferred Tax | 78.83 | 78.16 | -46.4 | -46.12 | -45.76 | -45.27 | -44.64 | -43.78 | -42.63 | -31.43 |
Other Assets | 44.46 | 64.04 | 34.88 | 36.4 | 47.71 | 14.31 | 44.37 | 36.53 | 29.96 | 65.03 |
Total Assets | 5,510.41 | 5,230.43 | 6,092.28 | 5,770.94 | 5,179.55 | 3,823.02 | 2,856.6 | 1,932.82 | 1,572.02 | 1,049.38 |
Contingent Liabilities | 65.03 | 117.45 | 62.87 | 100.46 | 190.28 | 259.35 | 196.18 | 167.59 | 223.24 | 104.84 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 631.83 |
Depreciation | 272.67 |
Interest (Net) | 54.1 |
Dividend Received | 1.64 |
Prov. and W/O (Net) | 5.37 |
P/L in Forex | -40.16 |
Others | -0.01 |
Total Adjustments (PBT and Ext... | 286.86 |
Operating Profit before Workin... | 918.69 |
Trade and 0ther Receivables | 39.05 |
Inventories | -168.28 |
Trade Payables | 56.04 |
Total Adjustments (OP before W... | -95.64 |
Cash Generated from/(used in) ... | 823.05 |
Direct Taxes Paid | -19.85 |
Total Adjustments(Cash Generat... | -19.85 |
Cash Flow before Extraordinary... | 803.2 |
Net Cash from Operating Activi... | 803.2 |
Purchased of Fixed Assets | -327.47 |
Sale of Fixed Assets | 11.56 |
Purchase of Investments | -8.33 |
Interest Received | 1.99 |
Net Cash used in Investing Act... | -320.61 |
Of the Short Term Borrowings | -205.41 |
Of Financial Liabilities | -25.82 |
Dividend Paid | -157.25 |
Interest Paid | -49.37 |
Net Cash used in Financing Act... | -437.86 |
Net Profit before Tax and Extr... | 704.23 |
Depreciation | 271.14 |
Interest (Net) | 51.67 |
Dividend Received | 1.64 |
P/L on Sales of Assets | 0.58 |
Prov. and W/O (Net) | 5.37 |
P/L in Forex | -40.15 |
Others | -0.01 |
Total Adjustments (PBT and Ext... | 284.21 |
Operating Profit before Workin... | 988.44 |
Trade and 0ther Receivables | -127.21 |
Inventories | -77.94 |
Trade Payables | 24.31 |
Total Adjustments (OP before W... | -205.64 |
Cash Generated from/(used in) ... | 782.8 |
Direct Taxes Paid | -10.03 |
Total Adjustments(Cash Generat... | -10.03 |
Cash Flow before Extraordinary... | 772.77 |
Net Cash from Operating Activi... | 772.77 |
Purchased of Fixed Assets | -324.52 |
Sale of Fixed Assets | 0.19 |
Interest Received | 1.99 |
Invest.In Subsidiaires | -8.32 |
Net Cash used in Investing Act... | -329.02 |
Of the Short Term Borrowings | -215.04 |
Of Financial Liabilities | -24.25 |
Dividend Paid | -157.25 |
Interest Paid | -48.74 |
Net Cash used in Financing Act... | -445.29 |
Company Details
Registered Office |
|
Address | Alembic Road, |
City | Vadodara |
State | Gujarat |
Pin Code | 390003 |
Tel. No. | 91-0265-2280550 |
Fax. No. | 91-0265-2282506 |
apl.investors@alembic.co.in | |
Internet | http://www.alembic-india.com |
Registrars |
|
Address | Alembic Road |
City | Vadodara |
State | Gujarat |
Pin Code | 390003 |
Tel. No. | 91-0265-2280550 |
Fax. No. | 91-0265-2282506 |
apl.investors@alembic.co.in | |
Internet | http://www.alembic-india.com |
Management |
|
Name | Designation |
Chirayu R Amin | Chairman & CEO |
Rajkumar Baheti | Director (Finance) & CFO |
Pranav Amin | Managing Director |
Shaunak Amin | Managing Director |
Archana Hingorani | Independent Director |
Ashok Barat | Independent Director |
Manisha Saraf | Company Sec. & Compli. Officer |
Jai S Diwanji | Independent Director |
Manish Kejriwal | Independent Director |